Non-Traditional Antimicrobials Can Follow Regulatory Path Laid By Small Molecule Antibiotics, US FDA Says

 
• By Sue Sutter
  
Pew AMR
Officials from US FDA's veterinary, drugs, devices and biologics centers discuss initiatives to spur new antimicrobial product development. • Source: Photo by Sue Sutter

More from Approval Standards

More from Pathways & Standards